A recent study demonstrated that IgG antibodies play a key role in controlling IgE-mediated inflammatory responses in patients with nasal polyps, by interfering with allergens potentially binding to cell-bound IgEs (145). This evidence concerns the gene IGHE and nasal cavity polyp.